glp-1 receptor agonist market top selling drugs us Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 The Multi-Sector Impacts of GLP-1RA
Description
GLP-1 for Alzheimers
Known to trigger the release of insulin secretion, this peptide had so far proven disappointing as a drug candidate for treating diabetes
The patients who received 5 mg were found to have 0.70% in HbA1c level versus 0.72% in the group that received 15 mg [25]
On the contrary, for the same treatment period but at a drug concentration of 1.0 mg, there was only 1 case of thyroid cancer (Table 4)
Especially for older adults who have the most to gain from a drug that lowers the risk of heart disease but also need to preserve muscle strength combining a muscle-preserving drug with GLP-1 agonists could be a big deal
